Search results for: Amanda Cole
Filter search results
How Restrictive are NICE ‘Optimised’ Decisions?
27 April 2023
…of recommendations would help paint a more accurate picture of recommended levels of patient access associated with NICE decision outcomes. Citations Bulut, M., O’Neill, P. and Cole, A. (2020) NICE…
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
…Cole received no funding for this article, but has undertaken related work on the topic of the IRA with funding from PhRMA. References CMS, 2023. Medicare Drug Price Negotiation Program:…
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
…and Culyer, A.J., 2010. Discounting and decision making in the economic evaluation of health care technologies’. Health Economics, 20, pp.2–15. 10.1002/hec.1612. Cole, M.A., 2003. Development, trade, and the environment: how…
Drug shortages are on the rise – but what is their impact?
16 September 2024
…Cole, A. and Cookson, G., 2024. The Dynamics of Drug Shortages. [online] OHE – Leading intellectual authority on global health economics. Available at: https://www.ohe.org/publications/the-dynamic-of-drug-shortages [Accessed 10 May 2024]. Nonzee, N.J. and Luu,…
OHE Lunchtime Seminar: How Cost-Effective are New Cancer Drugs in the U.S.?
18 September 2017, 11:00pm
…University of Pennsylvania. Prof. Lichtenberg previously taught at Harvard University, the University of Pennsylvania, and Ecole Polytechnique. He has served as an expert for the Federal Trade Commission, the U.S….
OHE Response to Public Consultation on NICE Principles
7 February 2019
…to explore the trade-offs being made in the allocation of taxation budgets across the public sector For more information, please contact Koonal Shah. Cowles, E., Marsden, G., Cole, A. and…
Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs
12 March 2019
…be downloaded from the ICER website here. Cole, A., Towse, A., Segel C.S., Henshall, C., Pearson, S.D., 2019. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for…
Assessing the Life-cycle Value of Second-generation Antipsychotics in Sweden and the UK
17 July 2019
…(2018). R&D, Competition and Diffusion of Innovation in EU: the case of Hepatitis C. OHE Research Paper 18/06, London: Office of Health Economics. Available at: https://www.ohe.org/publications/rd-competition-and-diffusion-innovation-eu-case-hepatitis-c Cole, A., Towse,…
New Member of the EuroQol Group: OHE’s Dr Yan Feng
6 March 2017
…with journal). Cole, A., Shah, K., Mulhern, B., Feng, Y., Devlin, N., 2016. Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment (under revision with journal). Feng, Y, Hole, A.,…